You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hallucinogens

Showing 51 - 66 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Other Drug Substance Abuse Trial in United States (Iwin: Individual Well-Being Navigator)

Completed
  • Other Drug Substance Abuse
  • Iwin: Individual Well-Being Navigator
  • Watertown, Massachusetts
  • +3 more
Mar 3, 2020

HIV, Depression Trial in United States (Health and Wellness Combined Cognitive Behavioral Therapy and a Medication Management

Completed
Has Results
  • HIV
  • Depression
  • Health and Wellness Combined Cognitive Behavioral Therapy and a Medication Management Algorithm
  • Enhanced Standard of Care
  • Alhambra, California
  • +12 more
Mar 2, 2021

Healthy Trial in Baltimore (Psilocybin)

Completed
Has Results
  • Healthy
  • Baltimore, Maryland
    Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Med
Aug 21, 2019

Drug Use Trial in Almaty (Kazakhstani Family Together, Usual Care Alone)

Completed
  • Drug Use
  • Kazakhstani Family Together
  • Usual Care Alone
  • Almaty, Kazakhstan
    Columbia University Global Heath Research Center of Central Asia
May 20, 2019

Prevalence of New Psychoactive Substances Use

Unknown status
  • Addiction
    • (no location specified)
    Oct 3, 2018

    Depressive Symptoms, Anxiety, Cancer Trial in Baltimore (psilocybin)

    Completed
    Has Results
    • Depressive Symptoms
    • +2 more
    • Baltimore, Maryland
      Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Cam
    Jun 19, 2018

    Drug Use, Alcohol Use, CHF Trial in Philadelphia (Specialized Community Disease Management, Treatment As Usual)

    Completed
    Has Results
    • Drug Use
    • +7 more
    • Specialized Community Disease Management
    • Treatment As Usual
    • Philadelphia, Pennsylvania
      Temple University Hospital
    Nov 13, 2017

    Alcohol Dependence, Dual Diagnosis, Drug Dependence Trial in Charleston (Arm 1 GMI, Arm 2 IHMD, Arm 3 TCC)

    Completed
    Has Results
    • Alcohol Dependence
    • +2 more
    • Arm 1 GMI
    • +2 more
    • Charleston, South Carolina
      Ralph H. Johnson VA Medical Center, Charleston, SC
    Jul 10, 2018

    Substance Use Disorders, Substance Abuse, Substance Use Trial in Istanbul (Exercise group, Control group)

    Completed
    • Substance Use Disorders
    • +2 more
    • Exercise group
    • Control group
    • Istanbul, Turkey
      Rustem Mustafaoğlu
    Apr 5, 2018

    Opioid Abuse, Opioid Addiction, Stimulant Abuse Trial in Baltimore (tramadol, , Hydromorphone)

    Completed
    Has Results
    • Opioid Abuse
    • +3 more
    • Baltimore, Maryland
      Behavioral Pharmacology Research Unit
    Sep 14, 2017

    Opiate Dependence, Drug Dependence, Substance Dependence Trial (Suboxone (SCH 000484), Subutex (SCH 028444))

    Completed
    Has Results
    • Opiate Dependence
    • +2 more
    • Suboxone (SCH 000484)
    • Subutex (SCH 028444)
    • (no location specified)
    Jun 2, 2017

    Drug Use, Harmful Use Trial in Los Angeles (Quit Using Drugs Intervention Trial, Health behavior maintenance)

    Completed
    • Drug Use
    • Harmful Use
    • Quit Using Drugs Intervention Trial
    • Health behavior maintenance
    • Los Angeles, California
      UCLA
    Nov 16, 2016

    Substance Use, Sexual Risk Behavior Trial in Hollywood, Venice Beach (Group MI risk reduction program)

    Completed
    • Substance Use
    • Sexual Risk Behavior
    • Group MI risk reduction program
    • Hollywood, California
    • +1 more
    Apr 15, 2016

    Psilocybin, Hallucinogens, Pharmacologic Actions Trial in Baltimore (psilocybin)

    Completed
    • Psilocybin
    • +5 more
    • Baltimore, Maryland
      Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Med
    May 19, 2014

    Drug Use, Alcohol Use Trial in Philadelphia (SBIRT, SBIRT+)

    Completed
    • Drug Use
    • Alcohol Use
    • SBIRT
    • SBIRT+
    • Philadelphia, Pennsylvania
    • +2 more
    Jun 15, 2015

    Healthy Trial in Antwerpen (JNJ-40411813 50 mg, JNJ-40411813 100 mg, Placebo)

    Completed
    • Healthy
    • JNJ-40411813 50 mg
    • +2 more
    • Antwerpen, Belgium
      (unnamed)
    Aug 27, 2013